AstraZeneca PLC (STO:AZN)
1,728.00
+26.00 (1.53%)
At close: Feb 10, 2026
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of 2.63 trillion as of February 10, 2026. Its market cap has increased by 10.52% in one year.
Market Cap
2.63T
Enterprise Value
2.85T
Revenue
547.72B
Ranking
n/a
PE Ratio
29.71
Stock Price
1,728.00
Market Cap Chart
Since May 28, 1993, AstraZeneca's market cap has increased from 50.94B to 2.63T, an increase of 5,064.95%. That is a compound annual growth rate of 12.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 2.63T | -0.82% |
| Dec 31, 2025 | 2.65T | 17.98% |
| Dec 31, 2024 | 2.25T | 6.54% |
| Dec 29, 2023 | 2.11T | -3.33% |
| Dec 30, 2022 | 2.18T | 32.64% |
| Dec 31, 2021 | 1.65T | 52.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 136.81B |
| Getinge AB | 55.35B |
| Camurus AB | 41.33B |
| Sectra AB | 38.65B |
| Asker Healthcare Group AB | 30.64B |
| Medicover AB | 30.57B |
| BioArctic AB | 28.76B |
| Elekta AB | 21.07B |